Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NZE/AFT stock hub

NZE/AFT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NZE/AFTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

383.8M

New Zealand Stock Exchange

Market data

Price

Recent price action with selectable time range.

NZE/AFTNZE/AFT

—

Loading chart…

In the news

Latest news · NZE/AFT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.3

P25 n/aP50 n/aP75 n/a

Trailing P/E22.6

P25 n/aP50 n/aP75 n/a

ROE18.3

P25 n/aP50 n/aP75 n/a

ROIC13.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NZE/AFT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

NZD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	New Zealand
Country code	NZ
Employees	119
Employees Change	9%
Employees Change Percent	8.18
Enterprise value	NZD 408.4M
Exchange	New Zealand Stock Exchange
Financial currency	NZD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	NZAFTE0001S4
Last refreshed	2026-05-10
Market cap	NZD 383.8M
Price	NZD 3.66
Price currency	NZD
Rev Per Employee	1,985,294.12x
Sector	Healthcare
Sic	2834
Symbol	nze/AFT
Website	https://www.aftpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.55%
EV Earnings	23.41x
EV/EBIT	16.89x
EV/EBITDA	15.67x
EV/FCF	44.86x
EV/Sales	1.73x
FCF yield	2.37%
Forward P/E	21.28x
P/B ratio	3.92x
P/E ratio	22.62x
P/S ratio	1.62x
PE Ratio10 Y	33.91x
PE Ratio3 Y	23.1x
PE Ratio5 Y	25.53x
PEG ratio	0.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.24%
EBITDA Margin	10.68%
FCF margin	3.85%
Gross margin	44.53%
Gross Profit	NZD 105.2M
Gross Profit Growth	14.71%
Gross Profit Growth Q	37.27%
Gross Profit Growth3 Y	6.02%
Gross Profit Growth5 Y	7.59%
Net Income	NZD 17.4M
Net Income Growth	50.31%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	3.78%
Net Income Growth5 Y	10.37%
Pretax Margin	9.87%
Profit Margin	7.38%
Profit Per Employee	NZD 146,605
Profitable Years	6
ROA	9.46
Roa5y	8.62
ROCE	23.98
ROE	18.27
Roe5y	23.3
ROIC	13.9
Roic5y	16.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.23%
Cagr1y	34.04%
Cagr3y	4.04%
Cagr5y	-4.99%
EPS Growth	59.08
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	2.82
EPS Growth5 Y	9.75
FCF Growth	-64.38%
FCF Growth Q	-90.2%
FCF Growth3 Y	-31.84%
FCF Growth5 Y	-4.45%
OCF Growth	-63.88%
OCF Growth Q	-89.07%
OCF Growth10 Y	4.47%
OCF Growth3 Y	-31.44%
OCF Growth5 Y	-4.37%
Revenue Growth	19.01x
Revenue Growth Q	32.56x
Revenue Growth Quarters	17x
Revenue Growth Years	12x
Revenue Growth3 Y	6.53x
Revenue Growth5 Y	8.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	NZD 1.48
Assets	NZD 171.6M
Cash	NZD 12.1M
Current Assets	NZD 107M
Current Liabilities	NZD 70.8M
Debt	NZD 37.9M
Debt EBITDA	NZD 1.45
Debt Equity	NZD 0.39
Debt FCF	NZD 4.16
Equity	NZD 98M
Interest Coverage	8.98
Liabilities	NZD 73.6M
Long Term Assets	NZD 64.6M
Long Term Liabilities	NZD 2.9M
Net Cash	NZD -25.8M
Net Cash By Market Cap	NZD -6.71
Net Debt EBITDA	NZD 1.02
Net Debt Equity	NZD 0.26
Net Debt FCF	NZD 2.83
Tangible Book Value	NZD 38.8M
Tangible Book Value Per Share	NZD 0.37
WACC	6.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.51
Inventory Turnover	2.48
Net Working Capital	NZD 59.1M
Quick ratio	0.69
Working Capital	NZD 36.2M
Working Capital Turnover	NZD 5.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	7.83%
Dividend Growth	12.5%
Dividend Growth Years	3%
Dividend per share	NZD 0.02
Dividend Years	3
Dividend Yield	0.49%
Ex Div Date	2025-06-18
Last Dividend	NZD 0.02
Payout Frequency	Annual
Payout Ratio	10.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	24.7%
1Y total return	34.01%
200-day SMA	3.25
3Y total return	12.61%
50-day SMA	3.52
50-day SMA vs 200-day SMA	50over200
5Y total return	-22.58%
All Time High	5.65
All Time High Change	-35.22%
All Time High Date	2020-11-10
All Time Low	1.7
All Time Low Change	115.29%
All Time Low Date	2019-04-16
ATR	0.04
Beta	0.4
Beta1y	-0.31
Beta2y	-0.08
Ch YTD	8.28
High	3.66
High52	3.8
High52 Date	2026-01-30
High52ch	-3.68%
Low	3.61
Low52	2.51
Low52 Date	2025-06-24
Low52ch	45.82%
Ma50ch	4.07%
Price vs 200-day SMA	12.58%
RSI	64.66
RSI Monthly	58.86
RSI Weekly	58.23
Sharpe ratio	1.11x
Sortino ratio	2.11
Total Return	8.32%
Tr YTD	8.28
Tr1m	4.57%
Tr1w	4.57%
Tr3m	1.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NZD 24.2M
Operating Income Growth	37.06
Operating Income Growth3 Y	-0.06
Operating Income Growth5 Y	4.22
Operating margin	10.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,477,454%
Net Borrowing	2,397,000
Shares Insiders	69.39%
Shares Institutions	8.18%
Shares Out	104,866,260
Shares Qo Q	9.46%
Shares Yo Y	-7.83%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	NZD 9.1M
Average Volume	10,856.9x
Bv Per Share	0.95
CAPEX	NZD -195,000
Ch10y	22.82
Ch1m	4.57
Ch1w	4.57
Ch1y	33.09
Ch3m	1.67
Ch3y	10.91
Ch5y	-23.75
Ch6m	10.57
Change	1.67%
Change From Open	1.39
Close	3.6
Days Gap	0.28
Depreciation Amortization	1,042,000
Dollar Volume	29,433.7
Earnings Date	2026-05-20
EBIT	NZD 24.2M
EBITDA	NZD 25.2M
EPS	NZD 0.16
F Score	5
FCF	NZD 9.1M
FCF EV Yield	2.23x
FCF Per Share	NZD 0.09
Financing CF	-2,176,000
Fiscal Year End	March
Founded	1,997
Graham Number	1.85506
Graham Upside	-49.32
Income Tax	NZD 6.7M
Investing CF	-6,507,000
Is Primary Listing	1
Last Earnings Date	2026-02-18
Last Report Date	2025-09-30
Lynch Fair Value	NZD 1.68
Lynch Upside	-54.17
Ma150	3.45
Ma150ch	6.06%
Ma20	3.57
Ma20ch	2.49%
Net CF	526,000
Next Earnings Date	2026-05-20
Open	3.61
P FCF Ratio	42.16
P OCF Ratio	41.27
Payment Date	2025-07-04
Position In Range	100
Ppne	3,596,000
Price Date	2026-05-08
Price EBITDA	NZD 15.21
Ptbv Ratio	9.9
Relative Volume	0.74x
Revenue	236,250,000x
SBC By Revenue	-0x
Share Based Comp	-5,000
Tax By Revenue	2.85x
Tax Rate	28.87%
Tr6m	10.57%
Volume	8,042
Z Score	4.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NZE/AFT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.02 annual per share

Payout ratio

+10.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+8.3%

Next ex-dividend date: 2025-06-18

Performance

NZE/AFT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NZE/AFT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.2%

Share of float held by funds and institutions

Insider ownership

+69.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-7.8%

Negative means the company is buying back shares.

Technical

NZE/AFT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.7

Neutral momentum band

Price vs 200-day MA

+12.6%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

1.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NZE/AFT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nze/AFT stock rating?

nze/AFT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nze/AFT analysis?

The full report lives at /stocks/nze/AFT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nze/AFT?

The latest report frames nze/AFT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nze/AFT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.